Zusammenfassung
Gicht ist eine Stoffwechselkrankheit, die mit erhöhten Harnsäurespiegeln im Serum einhergeht. Diese sind zunächst symptomlos. Gichtkomplikationen entstehen durch kristalline Ausfällung der Harnsäure. In der Synovia von Gelenken führt dies zu schmerzhaften Gichtanfällen, im Gewebe zu immunologischer Reaktion mit Knötchenbildung (Tophi), in der Niere zu Uratsteinen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Literatur
Janssens H, Lucassen P, Van de Laar F, Janssen M, Van de Lisdonk E (2008): Systemic corticosteroids for acute gout. Cochrane Database Syst Rev. 2008 Apr 16; (2): CD005521.
Lin KC, Lin HY, Chou P (2000): Community based epidemiological study on hyperuricemia and gout in Kin-Hou. J Rheumatol 27: 1045–1050.
Löffler W, Simmonds HA, Gröbner W (1983): Gout and uric acid nephropathy: Some new aspects in diagnosis and treatment. Klin Wochenschr 61: 1223–1239.
Love BL, Barrons R, Veverka A, Snider KM (2010): Urate-lowering therapy for gout: focus on febuxostat. Pharmacotherapy 30: 594–608.
Sundy JS (2010): Progress in the pharmacotherapy of gout. Curr Opin Rheumatol 22: 188–193.
Suresh E, Das P (2012): Recent advances in management of gout. QJM 105: 407–417.
Tayar JH, Lopez-Olivo MA, Suarez-Almazor ME (2012): Febuxostat for treating chronic gout. Cochrane Database Syst Rev. 2012 Nov 14; 11: CD008653.
Zhang W, Doherty M, Pascual E, Bardin T, Barskova V, Conaghan P, Gerster J, Jacobs J, Leeb B, Lioté F, McCarthy G, Netter P, Nuki G, Perez-Ruiz F, Pignone A, Pimentão J, Punzi L, Roddy E, Uhlig T, Zimmermann-Gòrska I; EULAR Standing Committee for International Clinical Studies Including Therapeutics (2006a): EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65: 1301–1311.
Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P, Gerster J, Jacobs J, Leeb B, Lioté F, McCarthy G, Netter P, Nuki G, Perez-Ruiz F, Pignone A, Pimentão J, Punzi L, Roddy E, Uhlig T, Zimmermann-Gòrska I; EULAR Standing Committee for International Clinical Studies Including Therapeutics (2006b): EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics ESCISIT). Ann Rheum Dis 65: 1312–1324.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin, Heidelberg
About this chapter
Cite this chapter
Mühlbauer, B., Schmidt, G. (2013). Gichtmittel. In: Schwabe, U., Paffrath, D. (eds) Arzneiverordnungs-Report 2013. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-37124-0_25
Download citation
DOI: https://doi.org/10.1007/978-3-642-37124-0_25
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-37123-3
Online ISBN: 978-3-642-37124-0
eBook Packages: Medicine (German Language)